Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer
Clinical trial NCT02599714 · COMPLETED
Trial details
- NCT number
- NCT02599714
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-07
- Primary completion
- 2018-03-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.